Udier Blagovic, who holds a PhD in Organic Chemistry from Yale University, joins Nouscom from Versant Ventures, where she held the position of Operating Principal. Before Versant, she was the Global Head of Neurodegeneration at Novartis, and prior to that, she worked in the healthcare sector of McKinsey & Company in Chicago. 

Nouscom has also announced the appointment of new Board Directors who will join Dr. Guido Magni and Dr Joachim Rothe: Dr Jean-Paul Prieels will join as Non-Executive Director; Dr Vincent Brichard and Dr Gianni Gromo will join as Board Observers.